Gsk (GSK) Cash & Equivalents Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
14.21% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
4.20% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
11.85% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-18.13% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-27.48% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
15.61% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-7.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
2.10% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
1.15% |
| Date | Value |
|---|
| Mar 31, 2026 |
9.72% |
| Dec 31, 2025 |
1.15% |
| Sep 30, 2025 |
1.53% |
| Jun 30, 2025 |
-16.14% |
| Mar 31, 2025 |
-27.44% |
| Dec 31, 2024 |
-4.82% |
| Sep 30, 2024 |
-4.49% |
| Jun 30, 2024 |
-8.60% |
| Mar 31, 2024 |
-18.59% |
| Dec 31, 2023 |
-24.02% |
| Sep 30, 2023 |
-26.99% |
| Jun 30, 2023 |
-27.09% |
| Mar 31, 2023 |
-16.86% |
| Dec 31, 2022 |
-10.31% |
| Sep 30, 2022 |
-7.15% |
| Jun 30, 2022 |
15.36% |
| Mar 31, 2022 |
39.86% |
| Dec 31, 2021 |
4.94% |
| Sep 30, 2021 |
-1.25% |
| Jun 30, 2021 |
-3.87% |
| Mar 31, 2021 |
5.60% |
| Dec 31, 2020 |
17.75% |
| Sep 28, 2020 |
18.54% |
| Jun 30, 2020 |
25.80% |
| Mar 31, 2020 |
3.05% |
| Dec 31, 2019 |
-0.20% |
| Sep 30, 2019 |
-4.34% |
| Jun 30, 2019 |
-6.99% |
| Mar 31, 2019 |
-10.18% |
| Dec 31, 2018 |
-17.40% |
| Sep 30, 2018 |
-23.32% |
| Jun 30, 2018 |
-23.11% |
| Mar 31, 2018 |
-29.07% |
| Dec 31, 2017 |
-9.53% |
| Sep 30, 2017 |
-3.28% |
| Jun 30, 2017 |
-1.45% |
| Mar 31, 2017 |
-1.33% |
| Dec 31, 2016 |
-12.09% |
| Sep 30, 2016 |
6.36% |
| Jun 30, 2016 |
14.75% |
| Mar 31, 2016 |
7.61% |
| Dec 31, 2015 |
-88.87% |
| Sep 30, 2015 |
26.99% |
| Jun 30, 2015 |
1.20% |
| Mar 31, 2015 |
20.79% |
| Dec 31, 2014 |
-91.82% |
| Sep 30, 2014 |
-7.68% |
| Jun 30, 2014 |
-17.66% |
| Mar 31, 2014 |
-17.63% |
| Dec 31, 2013 |
-2.17% |
| Sep 30, 2013 |
-19.49% |
| Jun 30, 2013 |
-23.67% |
| Mar 31, 2013 |
-18.16% |
| Dec 31, 2012 |
743.82% |
| Sep 30, 2012 |
-20.38% |
| Jun 30, 2012 |
12.23% |
| Mar 31, 2012 |
-0.32% |
